Svb Wealth LLC Dexcom Inc Transaction History

Svb Wealth LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $75,452 - $96,067	684 Added 28.03%	3,124 $354,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1,142 - $1,401	10 Added 0.41%	2,440 $338,000
Q4 2023 Jan 30, 2024	BUY	$75.49 - $124.16 $183,440 - $301,708	2,430 New	2,430 $301,000
Q2 2023 Jul 24, 2023	SELL	$112.47 - $130.98 $70,068 - $81,600	-623 Reduced 21.61%	2,260 $290,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $64,272 - $75,964	-618 Reduced 17.65%	2,883 $334,000
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $23,284 - $33,611	274 Added 8.49%	3,501 $396,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $246,381 - $303,918	3,227 New	3,227 $260,000
Q4 2021 Feb 15, 2022	SELL	$129.87 - $162.82 $84,545 - $105,995	-651 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $17,820 - $23,911	167 Added 34.5%	651 $356,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $39,199 - $52,238	484 New	484 $207,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.